An N6-methyladenosine and target genes-based study on subtypes and prognosis of lung adenocarcinoma

被引:1
|
作者
Chu, Xiao [1 ]
Wang, Weiqing [1 ]
Sun, Zhaoyun [1 ]
Bao, Feichao [2 ]
Feng, Liang [1 ]
机构
[1] Fudan Univ, Peoples Hosp Shanghai 5, Dept Thorac Surg, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Thorac Surg, Affiliated Chest Hosp, Shanghai, Peoples R China
关键词
N-6-methyladenosine (m(6)A); consensus clustering; prognostic score; immune cells; nomogram; TUMOR; EXPRESSION; CELLS; E2F7;
D O I
10.3934/mbe.2022013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: Lung adenocarcinoma (LUAD) is a highly lethal subtype of primary lung cancer with a poor prognosis. N6-methyladenosine (m(6)A), the most predominant form of RNA modification, regulates biological processes and has critical prognostic implications for LUAD. Our study aimed to mine potential target genes of m(6)A regulators to explore their biological significance in subtyping LUAD and predicting survival. Methods: Using gene expression data from TCGA database, candidate target genes of m(6)A were predicted from differentially expressed genes (DEGs) in tumor based on M(6)A2 Target database. The survival-related target DEGs identified by Cox-regression analysis was used for consensus clustering analysis to subtype LUAD. Uni-and multi-variable Cox regression analysis and LASSO Cox-PH regression analysis were used to select the optimal prognostic genes for constructing prognostic score (PS) model. Nomogram encompassing PS score and independent prognostic factors was built to predict 3-year and 5-year survival probability. Results: We obtained 2429 DEGs in tumor tissue, within which, 1267 were predicted to m(6)A target genes. A prognostic m(6)A-DEGs network of 224 survival-related target DEGs was established. We classified LUAD into 2 subtypes, which were significantly different in OS time, clinicopathological characteristics, and fractions of 12 immune cell types. A PS model of five genes (C1QTNF6, THSD1, GRIK2, E2F7 and SLCO1B3) successfully split the training set or an independent GEO dataset into two subgroups with significantly different OS time (p < 0.001, AUC = 0.723; p = 0.017, AUC = 0.705).A nomogram model combining PS status, pathologic stage, and recurrence was built, showing good performance in predicting 3-year and 5-year survival probability (C-index = 0.708, 0.723, p-value = 0). Conclusion: Using candidate m(6)A target genes, we obtained two molecular subtypes and designed a reliable five-gene PS score model for survival prediction in LUAD.
引用
收藏
页码:253 / 270
页数:18
相关论文
共 50 条
  • [21] CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes
    Zheng, Yanfen
    Li, Xingyang
    Deng, Shuang
    Zhao, Hongzhe
    Ye, Ying
    Zhang, Shaoping
    Huang, Xudong
    Bai, Ruihong
    Zhuang, Lisha
    Zhou, Quanbo
    Li, Mei
    Su, Jiachun
    Li, Rui
    Bao, Xiaoqiong
    Zeng, Lingxing
    Chen, Rufu
    Zheng, Jian
    Lin, Dongxin
    He, Chuan
    Zhang, Jialiang
    Zuo, Zhixiang
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [22] CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes
    Yanfen Zheng
    Xingyang Li
    Shuang Deng
    Hongzhe Zhao
    Ying Ye
    Shaoping Zhang
    Xudong Huang
    Ruihong Bai
    Lisha Zhuang
    Quanbo Zhou
    Mei Li
    Jiachun Su
    Rui Li
    Xiaoqiong Bao
    Lingxing Zeng
    Rufu Chen
    Jian Zheng
    Dongxin Lin
    Chuan He
    Jialiang Zhang
    Zhixiang Zuo
    Nature Communications, 14
  • [23] STIL Regulated by N6-Methyladenosine Methyltransferase RBM15 can Facilitate Lung Adenocarcinoma Progression
    Li, Chunyan
    Huang, Zhiwen
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (10): : 5257 - 5266
  • [24] Emerging role of N6-methyladenosine RNA methylation in lung diseases
    Xu, Limin
    Zhou, Lingyan
    Yan, Chenxin
    Li, Liqin
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (20) : 1862 - 1872
  • [25] Importance of N6-methyladenosine RNA modification in lung cancer (Review)
    Wang, Yueyang
    Su, Xiaoming
    Zhao, Mingyao
    Xu, Mingchen
    Chen, Yueqi
    Li, Zhengyi
    Zhuang, Wenyue
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (06)
  • [26] N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
    Zhang, Meijing
    Luo, Tianhang
    Biao, Yang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [27] Predictive value of N6-methyladenosine (m6A)-related genes for prognosis and correlation with tumor microenvironment in gastric cancer
    Yin, Tengfei
    Zhao, Lang
    Yao, Shukun
    CHINESE MEDICAL JOURNAL, 2022, 135 (19) : 2360 - 2362
  • [28] The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
    Tan, Shuzhen
    Li, Zesong
    Li, Kai
    Li, Yingqi
    Liang, Guosheng
    Tang, Zhenye
    Kang, Jianhao
    Chen, Wenqing
    Li, Minhua
    Zou, Zhilin
    Pi, Guoliang
    Zhu, Xiao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [29] Predictive value of N6-methyladenosine (m6A)-related genes for prognosis and correlation with tumor microenvironment in gastric cancer
    Yin Tengfei
    Zhao Lang
    Yao Shukun
    中华医学杂志英文版, 2022, 135 (19)
  • [30] Deciphering N6-Methyladenosine-Related Genes Signature to Predict Survival in Lung Adenocarcinoma
    Zhu, Jie
    Wang, Min
    Hu, Daixing
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020